Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/8/24 16:30 | 2/7/24 | PCSA | Health | Drug | Pharmaceutical Preparations | Young David | MD | DO | P Resear | 5 | P.m | 174 | 1.08 | 0 | 161 | 11 | 1,677 | D | ||||||||||||||
2/1/24 18:32 | 1/31/24 | PCSA | Health | Drug | Pharmaceutical Preparations | Lin Patrick | MD | O | Chief Bu | 1 | P.m | 10 | 2.38 | 0 | 4 | 17 | 27 | D | ||||||||||||||
1/31/24 16:37 | 1/30/24 | PCSA | Health | Drug | Pharmaceutical Preparations | Ng George K | MD | DO | CEO | 1 | P | 27 | 2.70 | 0 | 10 | 100 | 20 | I | ||||||||||||||
1/31/24 16:34 | 1/30/24 | PCSA | Health | Drug | Pharmaceutical Preparations | Yorke Justin W | MD | D | 1 | P | 22 | 2.69 | 0 | 8 | 30 | 35 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |